Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...
GeneWerk’s Merger with Protagen Protein Services
Circle’s Business Combination with Concord Acquisition Corp
Goodwin Procter and Matheson advised Circle on the deal. Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. Circle announced its definitive business combination agreement with Concord...
Ambrx Biopharma’s $126 Million IPO
Goodwin Procter LLP and JunHe advised Goldman Sachs & Co. LLC and the other underwriters on the deal, while Wilson Sonsini Goodrich & Rosati and Maples...
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
Social Finance’s Business Combination with Social Capital Hedosophia Holdings Corp. V
Goodwin Procter LLP advised Social Finance on the deal. Social Finance, Inc. (SoFi) announced its business combination with SPAC Social Capital Hedosophia Holdings Corp. V (SCH) (NYSE:...
Akili Interactive’s $160 Million Equity and Debt Financing
Goodwin Procter LLP advised Akili Interactive on the deal. Akili Interactive announced its $160 million in combined equity and debt financing. Akili is the maker of EndeavorRx™,...
COMPASS Pathways’ $144 Million Shares Offering
Goodwin Procter LLP advised COMPASS Pathways plc on the deal. COMPASS Pathways plc (Nasdaq: CMPS) announced its public follow-on offering of 4,000,000 American Depositary Shares (“ADSs”) representing...
COMPASS Pathways’ $144 Million Shares Offering
Goodwin Procter LLP advised COMPASS Pathways plc on the deal. COMPASS Pathways plc (Nasdaq: CMPS) announced its public follow-on offering of 4,000,000 American Depositary Shares (“ADSs”) representing...
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Valneva SE’s $107.6 Million Global Offering
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Hogan Lovells and Cooley advised Valneva. Gide advised Goldman Sachs, Jefferies,...
Neuroelectrics’ $17.5 Million Series A Financing
Goodwin Procter LLP advised Neuroelectrics on the deal. Neuroelectrics announced its $17.5 million Series A financing led by Morningside Ventures. Neuroelectrics is developing a therapeutic platform that...